Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT01319422 · COMPLETED
Trial details
- NCT number
- NCT01319422
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.